Anticipating a substantial rise, the US Generic Pharmaceuticals Market is set to ascend from $91.96 billion in 2024 to an impressive $173.73 billion by 2035. This represents a compound annual growth rate (CAGR) of 5.95%. The market dynamics are largely influenced by a pronounced shift towards affordable medication options, reflecting increasing healthcare costs and a burgeoning demand for...